|
|
|
Volumn 19, Issue 2, 2001, Pages 121-122
|
|
Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
DRUG DERIVATIVE;
ETIDRONIC ACID;
RISEDRONIC ACID;
AGED;
ARTICLE;
BONE DENSITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
HUMAN;
INCIDENCE;
MIDDLE AGED;
POSTMENOPAUSE OSTEOPOROSIS;
RANDOMIZED CONTROLLED TRIAL;
SPINE FRACTURE;
AGED;
BONE DENSITY;
CALCIUM CHANNEL BLOCKERS;
ETIDRONIC ACID;
FEMALE;
HUMANS;
INCIDENCE;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
RANDOMIZED CONTROLLED TRIALS;
SPINAL FRACTURES;
|
|
EID: 0035290179
PISSN: 0392856X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
